Institutional investors purchased a net $6.5 million shares of OPK during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 24.56% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 8.9 Million shares of OPKO Health Inc
MERRILL LYNCH, PIERCE, FENNER & ... Bought 1.5 Million shares of OPKO Health Inc
FIRST TRUST ADVISORS LP Bought 1.3 Million shares of OPKO Health Inc